Skip to main content

Table 1 Patient characteristics and clinicopathological features of the 20 gastric tumors used in the study

From: Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival

Sex Females n = 5, males n = 15
Ethnicity Caucasian n = 18, Asian n = 2
Age at surgery Total: 68.7 years (±12.5)
Females: 65.7 years (±21.8)
Males: 69.7 years (±8.6)
Postoperative survival (deceased individuals) Total: 13.2 months (±8.8)
Females (n = 4): 16.6 months (±6.4)
Males (n = 10): 12.0 months (±9.7)
Postoperative survival (alive individuals at study end) Total: 45.8 months (±7.9)
Females (n = 1): 48.0 months
Males (n = 5): 44.9 months (±8.8)
Tumor size 49 mm (±27)
Tumor stage T1 2
T2 10
T3 5
T4 3
Nodal stage N0 10
N1 5
N2 3
N3 2
Histological type Intestinal 5
Diffuse 12
  Mixed 3
  1. Patient characteristics and clinicopathological features of the 20 gastric tumors used in the study. Values are the mean plus/minus standard deviation.